Manuel Litchman work email
- Valid
- Valid
- Valid
- Valid
Manuel Litchman personal email
Manuel Litchman phone numbers
As the President and CEO of Mustang Bio, a clinical-stage biopharmaceutical company, I lead a team of dedicated and talented professionals who are committed to developing and commercializing cell and gene therapies for hematologic cancers, solid tumors and rare genetic diseases. With 30 years of experience in the pharmaceutical and biotech industry, I have a proven track record of building and leading successful organizations, forging strategic partnerships, and advancing innovative therapies from bench to bedside.My passion for transforming the lives of patients with unmet medical needs stems from my background as a clinical hematologist-oncologist and a clinical researcher in oncology and cell and gene therapy. Prior to my current position, I have held leadership roles in general management, business development, and clinical research at Roche, Novartis, and Arvinas, where I have contributed to the development and launch of several first-in-class products, including the first FDA-approved CAR T therapy, Kymriah. I have also established and maintained strong collaborations with top academic institutions, such as St. Jude Children's Research Hospital, City of Hope, Mayo Clinic, and Fred Hutchinson Cancer Research Center, to accelerate the discovery and development of novel cell and gene therapies. I am driven by a vision of creating a better future for patients and their families, and I am proud to be part of the Mustang Bio team.
-
President And CeoMustang BioWaltham, Ma, Us
-
President & CeoMustang Bio Apr 2017 - PresentWorcester, Massachusetts, UsMustang Bio, Inc. (Nasdaq: MBIO), is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Mustang aims to acquire rights to these technologies by licensing or otherwise acquiring an ownership interest, to fund research and development, and to outlicense or bring the technologies to market. Mustang has partnered with top medical institutions to advance the development of CAR T therapies across multiple cancers, as well as a lentiviral gene therapy for X¬SCID. These institutions include St. Jude Children's Research Hospital, City of Hope, Fred Hutchinson Cancer Research Center, and Nationwide Children's Hospital.
-
President And CeoArvinas Inc. Jan 2015 - Feb 2017New Haven, Connecticut, UsArvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses their proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC(R) protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. -
Svp & Executive Global Program Head, Ctl019Novartis Pharmaceuticals Corporation Aug 2012 - Dec 2014Basel, Baselstadt, ChExecutive Global Program Head for the Novartis-University of Pennsylvania CAR T (chimeric antigen receptor modified T cells) collaboration. CTL019 (tisagenlecleucel) targets CD19-positive malignancies and is the lead program for this collaboration. In 2017 it became the first FDA-approved CAR T therapy and is now marketed in the US as Kymriah. -
Vp & Head, Oncology Business Development & LicensingNovartis Pharmaceuticals Corporation Jun 2001 - Jan 2012Basel, Baselstadt, Ch
-
Senior Equity AnalystSturza'S Institutional Research/Ursus Capital 2000 - 2001
-
Senior Clinical Research PhysicianNovartis Jun 1995 - Feb 2000Basel, Baselstadt, Ch
-
Associate DirectorHoffmann-La Roche Jul 1993 - Jun 1995Switzerland 🇨🇭 , Ch
Manuel Litchman Skills
Manuel Litchman Education Details
-
Yale School Of MedicineMedicine -
Princeton UniversityGermanic Languages & Literatures
Frequently Asked Questions about Manuel Litchman
What company does Manuel Litchman work for?
Manuel Litchman works for Mustang Bio
What is Manuel Litchman's role at the current company?
Manuel Litchman's current role is President and CEO.
What is Manuel Litchman's email address?
Manuel Litchman's email address is ma****@****tis.com
What is Manuel Litchman's direct phone number?
Manuel Litchman's direct phone number is +197346*****
What schools did Manuel Litchman attend?
Manuel Litchman attended Yale School Of Medicine, Princeton University.
What are some of Manuel Litchman's interests?
Manuel Litchman has interest in Education.
What skills is Manuel Litchman known for?
Manuel Litchman has skills like Lifesciences, Pharmaceutical Industry, Clinical Development, Oncology, Biotechnology, Clinical Trials, Hematology, Drug Discovery, Drug Development, Commercialization, Technology Transfer, Immunology.
Who are Manuel Litchman's colleagues?
Manuel Litchman's colleagues are Mehdi Amiri, Michael Phip, Faith Conroy, Yanni Mironidis, Tom Lee, Rhonda White, Zachary Kent.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial